soul trial oral semaglutide cardiovascular outcomes nejm 2025 results found to lower risk of heart failure events in people with type 2 diabetes A trial emulation in Nature
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




















